Theralase Technologies Inc.
TLTFF
$0.17
$0.014.06%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -50.85% | 33.06% | -6.77% | 32.87% | -56.29% |
| Total Depreciation and Amortization | -18.39% | 8.52% | 8.09% | -1.98% | -7.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 91.96% | -65.91% | 11.70% | -15.77% | 13.81% |
| Change in Net Operating Assets | 191.48% | -859.03% | 130.80% | -134.35% | 309.52% |
| Cash from Operations | 80.04% | -76.57% | 32.52% | -200.77% | 28.55% |
| Capital Expenditure | -101.99% | 374.55% | -35.80% | 82.00% | -818.37% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -97.35% | 374.55% | -35.80% | 82.00% | -818.37% |
| Total Debt Issued | -- | 175.00% | -- | -- | -- |
| Total Debt Repaid | -113.71% | 57.68% | 0.00% | -20.58% | -1.67% |
| Issuance of Common Stock | 6.40% | 53.44% | -31.67% | 221.04% | -32.83% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Financing | -17.15% | 72.67% | -21.98% | 251.10% | -36.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 707.66% | 190.08% | 140.78% | 35.29% | -120.05% |